| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 47.9412 | 41 |
| GSM780708 | Untreated after 4 days (C2_1) | 55.3261 | 60 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.9854 | 51 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.1127 | 54 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.7894 | 56 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.298 | 52 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 57.1296 | 62 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.5738 | 39 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 51.0401 | 52 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.1998 | 52 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.9621 | 54 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.996 | 58 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 56.8456 | 62 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.966 | 58 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 56.0387 | 61 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 56.7878 | 62 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 60.1483 | 65 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 59.8275 | 64 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 57.6986 | 63 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 58.1058 | 63 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 61.1454 | 65 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.4988 | 59 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 60.1968 | 65 |